Research Overview
DC-3R is an investigational synthetic triple receptor agonist targeting GIP, GLP-1, and glucagon receptors. Research examines how coordinated activation of these three pathways influences incretin signaling, glucose and lipid metabolism, energy expenditure, appetite-related signaling, and broader metabolic physiology.
Research Areas of Interest
- GIP, GLP-1 and glucagon receptor signaling
- Multi-receptor metabolic research
- Glucose and lipid metabolism
- Energy-expenditure and metabolic signaling
Product Details
| Strength | 10mg / 30mg |
|---|---|
| Category | Metabolic Signaling |
For Research Use Only. Not for human or veterinary use. Not intended to diagnose, treat, cure, or prevent any disease. Purchaser is responsible for compliance with applicable laws, regulations, and institutional policies.





Reviews
There are no reviews yet.